ATG5 and myocardial infarction: In AAV9-CMV-Cre Atg5 KO mice with deficient autophagy, AGGF1 protein therapy failed to increase the density of CD31-positive vessels in the heart after MI compared with IgG treatment (p > 0.05) (Fig 8A).